Gianpaolo Candiani
Newron Pharmaceuticals (Italy)(IT)
Publications by Year
Research Areas
Antimicrobial Resistance in Staphylococcus, Microbial Natural Products and Biosynthesis, Mycobacterium research and diagnosis, Bacterial Identification and Susceptibility Testing, Probiotics and Fermented Foods
Most-Cited Works
- → In-vitro and in-vivo antibacterial activity of BI 397, a new semi-synthetic glycopeptide antibiotic(1999)150 cited
- → Efficacy of the New Lantibiotic NAI-107 in Experimental Infections Induced by Multidrug-Resistant Gram-Positive Pathogens(2011)148 cited
- → Antibacterial Nucleoside-Analog Inhibitor of Bacterial RNA Polymerase(2017)140 cited
- → A Novel Lantibiotic Acting on Bacterial Cell Wall Synthesis Produced by the Uncommon Actinomycete Planomonospora sp.(2007)84 cited
- → Efficacy of Dalbavancin against Methicillin-Resistant Staphylococcus aureus in the Rat Granuloma Pouch Infection Model(2004)58 cited
- → Combinatorial modification of natural products: synthesis and in vitro analysis of derivatives of thiazole peptide antibiotic GE2270 A: A-ring modifications(2003)57 cited
- → Synthesis and antibacterial activity of a series of basic amides of teicoplanin and deglucoteicoplanin with polyamines(1992)32 cited
- → Candida albicans strains deficient in CHS7, a key regulator of chitin synthase III, exhibit morphogenetic alterations and attenuated virulence(2005)31 cited
- → Synthesis and Preliminary Biological Characterization of New Semisynthetic Derivatives of Ramoplanin(2007)30 cited
- → Pharmacological Properties of NAI-603, a Well-Tolerated Semisynthetic Derivative of Ramoplanin(2014)11 cited